Clinical Trial Update: Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab combined with oral metronomic cyclophosphamide for chest wall breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer, Chest Wall Tumor | Phase 2 | Status: RECRUITING